Dr. Morgan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
44 Binney St
# SW530
Boston, MA 02115Phone+1 617-632-5204Fax+1 617-632-3408
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1993 - 1996- Brigham and Women's HospitalResidency, Internal Medicine, 1990 - 1993
Harvard Medical SchoolClass of 1990
Certifications & Licensure
MA State Medical License 1993 - 2025- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07) Start of enrollment: 2006 Jun 01
Publications & Presentations
PubMed
- 6 citationsPhase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates.Candace L Haddox, Michael J Nathenson, Emanuele Mazzola, Jia-Ren Lin, Joanna Baginska
Clinical Cancer Research. 2024-04-01 - 11 citationsConcurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4/6 inhibition in GIST.Inga-Marie Schaefer, Matthew L Hemming, Meijun Z Lundberg, Matthew P Serrata, Isabel Goldaracena
British Journal of Cancer. 2022-11-01 - 4 citationsPrimary intra-abdominal melanoma arising in association with extracutaneous blue naevus: a report of two cases.Kabeer K. Shah, Andrew L. Folpe, Michael B. Miller, Jeffrey A. Morgan, Chandrajit P. Raut
Histopathology. 2021-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
